Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE
Clinical trial NCT01546909 · COMPLETED
Trial details
- NCT number
- NCT01546909
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2012-12-01
- Enrollment
- 278
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.